Oh EJ - Search Results

1

B-cell complement dependent cytotoxic crossmatch positivity is an independent risk factor for long-term renal allograft survival.

Hwang HS, Yoon HE, Choi BS, Oh EJ, Kim JI, Moon IS, Kim YS, Yang CW. Hwang HS, et al. Among authors: oh ej. J Korean Med Sci. 2011 Apr;26(4):528-33. doi: 10.3346/jkms.2011.26.4.528. Epub 2011 Mar 28. J Korean Med Sci. 2011. PMID: 21468260 Free PMC article.

2

Failure of systematic error detection with internal quality control program.

Park HI, Oh EJ, Park YJ, Han K, Yang CW. Park HI, et al. Among authors: oh ej. Ann Clin Lab Sci. 2008 Autumn;38(4):410-3. Ann Clin Lab Sci. 2008. PMID: 18988938 No abstract available.

3

Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.

Yoon HE, Kim SH, Kim JY, Oh EJ, Park SC, Choi BS, Choi YJ, Moon IS, Kim YS, Yang CW. Yoon HE, et al. Among authors: oh ej. Clin Transplant. 2009 Nov-Dec;23(6):812-8. doi: 10.1111/j.1399-0012.2008.00946.x. Epub 2008 Dec 19. Clin Transplant. 2009. PMID: 19191803

4

Clinical significance of monitoring circulating CD4+CD25+ regulatory T cells in kidney transplantation during the early posttransplant period.

Kim SH, Oh EJ, Ghee JY, Song HK, Han DH, Yoon HE, Choi BS, Yoon SK, Choi JY, Moon IS, Kim DG, Yang CW. Kim SH, et al. Among authors: oh ej. J Korean Med Sci. 2009 Jan;24 Suppl(Suppl 1):S135-42. doi: 10.3346/jkms.2009.24.S1.S135. Epub 2009 Jan 28. J Korean Med Sci. 2009. PMID: 19194543 Free PMC article.

5

Successful renal transplantation with desensitization in highly sensitized patients: a single center experience.

Yoon HE, Hyoung BJ, Hwang HS, Lee SY, Jeon YJ, Song JC, Oh EJ, Park SC, Choi BS, Moon IS, Kim YS, Yang CW. Yoon HE, et al. Among authors: oh ej. J Korean Med Sci. 2009 Jan;24 Suppl(Suppl 1):S148-55. doi: 10.3346/jkms.2009.24.S1.S148. Epub 2009 Jan 28. J Korean Med Sci. 2009. PMID: 19194545 Free PMC article.

6

Comparison of antibody monitoring system with flow cytometric crossmatch test in renal transplant recipients with high panel-reactive antibody.

Hwang HS, Hyoung BJ, Lee SY, Jeon YJ, Yoon HE, Kim JY, Choi BS, Oh EJ, Kim YS, Bang BK, Yang CW. Hwang HS, et al. Among authors: oh ej. Nephron Clin Pract. 2009;111(4):c260-4. doi: 10.1159/000209153. Epub 2009 Mar 17. Nephron Clin Pract. 2009. PMID: 19293595

7

[Comparative evaluation of ELISA and Luminex panel reactive antibody assays for HLA alloantibody screening].

Jung S, Oh EJ, Yang CW, Ahn WS, Kim Y, Park YJ, Han K. Jung S, et al. Among authors: oh ej. Korean J Lab Med. 2009 Oct;29(5):473-80. doi: 10.3343/kjlm.2009.29.5.473. Korean J Lab Med. 2009. PMID: 19893358 Korean.

8

Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.

Kim Y, Yang CW, Moon IS, Kim M, Lim J, Park YJ, Han K, Oh EJ. Kim Y, et al. Among authors: oh ej. Ann Clin Lab Sci. 2010 Fall;40(4):330-5. Ann Clin Lab Sci. 2010. PMID: 20947806

9

Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection.

Hwang HS, Sun IO, Yoon HE, Choi BS, Oh EJ, Kim JI, Moon IS, Kim YS, Yang CW. Hwang HS, et al. Among authors: oh ej. Hum Immunol. 2012 Apr;73(4):370-5. doi: 10.1016/j.humimm.2012.01.017. Epub 2012 Jan 31. Hum Immunol. 2012. PMID: 22342452

10

Pretransplant IFN-γ ELISPOT assay as a potential screening test to select immunosuppression protocols for patients receiving basiliximab induction therapy.

Kim Y, Park KH, Chung BH, Choi BS, Yang CW, Kim JI, Moon IS, Park YJ, Han K, Oh EJ. Kim Y, et al. Among authors: oh ej. Transl Res. 2012 Sep;160(3):230-6. doi: 10.1016/j.trsl.2012.02.009. Epub 2012 Mar 2. Transl Res. 2012. PMID: 22683414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters